| BCBS Oklahoma Medical Policies | KidneyIntelX and KidneyIntelX.dkd Testing | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Laboratory Testing Investigational Services | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Long-Acting Injectable Antiretroviral Agents for Treatment of | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Mirikizumab-mrkz | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Nonwearable Automatic External Defibrillators | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Ocrelizumab or Ocrelizumab and Hyaluronidase-ocsq | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Temporarily Implanted Nitinol Device (iTind) for Benign | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Teplizumab-mzwv | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Teprotumumab-trbw | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Tocilizumab and Associated Biosimilar(s) | 2026-04-01 |